Novel prodrug supramolecular nanoparticles capable of rapid mitochondrial-targeting and ROS-responsiveness for pancreatic cancer therapy

• DOI: 10.1039/d2nj01157c
• Publication Date: 2022-06-01T01:02:57Z
• Authors: Zheng Huang; Lixia Gao; Fang Guo; Dan Li; Yan Tang; Huaisong Hu; Yafei Luo; Dianyong Tang; Bochu Wang; Yimei Zhang
• Keywords: 0404 agricultural biotechnology; 04 agricultural and veterinary sciences; 3. Good health

Mitochondrial dysfunction is a feature of cancer cells and targeting cancer mitochondria has emerged as a promising anticancer therapy.